{"nct_id":"NCT03173092","title":"A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-03","start_date":"2017-11-13","start_date_type":"ACTUAL","primary_completion_date":"2026-11-30","primary_completion_date_type":"ESTIMATED","completion_date":"2026-11-30","completion_date_type":"ESTIMATED","phases":["PHASE4"],"tickers":["TAK"]}